Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Amrize LtdNYSE: AMRZ
Other Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other non-current liabilities rises 85.2% from a year ago
Other non-current liabilities stood at $1.71B at the end of Q2 FY2026, up 85.2% from a year earlier and up 7.4% from the prior quarter. Over 3 fiscal years it compounded at +45.7% a year.
Context
- Other non-current liabilities amounted to 7.0% of total assets at the end of Q2 FY2026, up 3.1 pp from a year earlier.
- Other non-current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other non-current liabilities keeps rising in the next quarterly balance sheet after a +85.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 2.7B USD
- Year-over-year change
- +211.3%
- 3-year CAGR
- +45.7%
| Period | Period end | Other Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.7B | +211.3% |
| FY2024 | 2024-12-31 | 868M | -6.7% |
| FY2023 | 2023-12-31 | 930M | +6.5% |
| FY2022 | 2022-12-31 | 873M | — |
Other Non-current Liabilities vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's Jun 2026 other non-current liabilities of $1.71B is the 3rd highest of the 7 companies compared; the peer median is $636.05M.
- Its year-over-year change of +85.2% is the 2nd highest of 7, against a peer median of +0.3%.
- Other non-current liabilities amounts to 7.0% of total assets for AMRZ, versus a peer median of 4.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.93B | +230.7% | +47.0% | 13.7% | |
| Jun 2026 | $2.61B | -4.5% | +15.0% | 4.5% | |
AMRZAmrize Ltd | Jun 2026 | $1.71B | +85.2% | +45.7% | 7.0% |
| Jun 2026 | $819.1M | -3.6% | -23.5% | 5.0% | |
| Jun 2026 | $453M | -20.7% | -40.7% | 3.6% | |
| Jun 2026 | $258.1M | +4.2% | +7.5% | 4.1% | |
| Jun 2026 | $68.24M | +5.8% | +17.2% | 1.7% | |
| Peer median (excluding AMRZ) | $636.05M | +0.3% | +11.2% | 4.3% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.